Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
J Urol. 2012 Dec;188(6):2084-8. doi: 10.1016/j.juro.2012.08.038. Epub 2012 Oct 18.
Nephron sparing surgery has been advocated for patients with bilateral renal masses but long-term functional and oncological outcomes are lacking. We report the outcomes of patients with bilateral renal masses and a minimum 10-year followup.
Patients with bilateral renal masses evaluated at our institution who were treated with initial surgery at least 10 years ago and underwent interventions on each renal unit were included in the analysis. Collected data included demographics, hereditary diagnosis, number of renal interventions, renal function and mortality status. Overall and renal cell carcinoma specific survival was assessed. Comparisons were made of renal function and overall survival between groups with 2 renal units and a surgically solitary kidney.
A total of 128 patients met study inclusion criteria. Median followup in our cohort was 16 years (mean 17, range 10 to 49). The median number of surgical interventions was 3 (range 2 to 10). Of the patients 87 (68%) required repeat interventions on the ipsilateral renal unit at last followup with a median of 6.2 years (range 0.7 to 21) between interventions. Overall and renal cell cancer specific survival was 88% and 97%, respectively. Six patients (4.7%) ultimately underwent bilateral nephrectomy. Although renal function was better preserved in patients with 2 kidneys (70 vs 53 ml/minute/1.73 m(2), p = 0.0002), there was no difference in overall survival between those with bilateral kidneys or a surgically solitary kidney.
At a minimum 10-year followup after initial surgery, nephron sparing surgery allowed for excellent oncological and functional outcomes. Despite the need for repeat surgical interventions, nephron sparing surgery enabled dialysis to be avoided in more than 95% of patients.
保肾手术已被提倡用于双侧肾脏肿块患者,但缺乏长期的功能和肿瘤学结果。我们报告了至少有 10 年随访的双侧肾脏肿块患者的结果。
本研究纳入了在我们机构接受评估的双侧肾脏肿块患者,这些患者在至少 10 年前接受了初始手术治疗,并且对每个肾脏单位进行了干预。收集的数据包括人口统计学、遗传性诊断、肾脏干预次数、肾功能和死亡率。评估了总体生存率和肾细胞癌特异性生存率。比较了两组患者的肾功能和总体生存率,两组患者分别为两个肾脏单位和手术孤立肾脏。
共有 128 名患者符合研究纳入标准。本队列的中位随访时间为 16 年(平均 17 岁,范围 10 至 49 岁)。中位手术干预次数为 3 次(范围 2 至 10 次)。在最后一次随访时,87 名患者(68%)需要对同侧肾脏单位进行重复干预,两次干预之间的中位时间为 6.2 年(范围 0.7 至 21 年)。总体生存率和肾细胞癌特异性生存率分别为 88%和 97%。最终有 6 名患者(4.7%)接受了双侧肾切除术。尽管双侧肾脏患者的肾功能保存更好(70 与 53ml/min/1.73m2,p=0.0002),但双侧肾脏或手术孤立肾脏患者的总体生存率无差异。
在初始手术后至少 10 年的随访中,保肾手术可获得良好的肿瘤学和功能结果。尽管需要重复手术干预,但保肾手术使超过 95%的患者避免了透析。